NDC 58602-865 – Guaifenesin
Guaifenesin 1200 mg/1 · Tablet, Extended Release · Oral
Product NDC58602-865
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- Aurohealth LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA210453
- Marketed since
- March 11, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 1200 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58602-865-03 | 3 BLISTER PACK in 1 CARTON (58602-865-03) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Mar 11, 2021 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 60687-874 Guaifenesin 300 mg/15mL · Solution · American Health Packaging
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 24689-144 Guaifenesin 400 mg/1 · Tablet · APNAR PHARMA LP
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-857 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC